Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,860.93
+36.241.99%
Number of Gainers:13
Number of Losers:5
Number of Flat:1
PE:- -
High:1,861.33
Open:1,823.22
Low:1,819.29
Close:1,824.74
Volume:51.69M
Turnover:4.99B
Market Cap:1.51T
Float Cap:1.48T

Loading ...

Moderna Appoints Juan Andres as Chief Operating Officer

Reuters
·
Sep 30

Ocugen to Participate in Upcoming Scientific Conferences

GlobeNewswire
·
Sep 30

Moderna Price Target Raised to $80.00/Share from $60.00 by Citigroup

Dow Jones
·
Sep 30

Moderna : Citigroup Cuts to Sell from Neutral; Raises Target Price to $80 from $60

THOMSON REUTERS
·
Sep 30

Moderna sinks 4% to $195.42 after Citi downgrades to Sell

TIPRANKS
·
Sep 30

Analysts Are Bullish on Top Healthcare Stocks: Abbott Laboratories (ABT), Tectonic Therapeutic (TECX)

TIPRANKS
·
Sep 30

AstraZeneca Hedges Threat to Oncology Portfolio

Dow Jones
·
Sep 30

Hong Kong Stocks Midday Review: Hang Seng Index Slips 0.04% in Morning Session, CRO-Related Shares Lead Gains

Stock News
·
Sep 30

NanoViricides Sets President Anil Diwan Base Salary at $400,000 Under Extension Agreement

Reuters
·
Sep 30

Equillium Posts New Preclinical EQ504 Data in Ulcerative Colitis at International AHR Conference

Reuters
·
Sep 30

Johnson: AI Providers Committed to Building Trust

THOMSON REUTERS
·
Sep 30

Johnson: We Can Keep Edge in a Safe Way

THOMSON REUTERS
·
Sep 30

Johnson: We'LL Continue to Assess and Deliberate in Coming Days

THOMSON REUTERS
·
Sep 30

Bernstein Remains a Buy on AstraZeneca (AZN)

TIPRANKS
·
Sep 30

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-09-29

Reuters
·
Sep 29

NanoViricides ‘actively exploring’ additional required funding

TIPRANKS
·
Sep 29

Premarket: Nasdaq Futures Rise 0.45% as Traders Eye Trump AI Luncheon

Deep News
·
Sep 29

J&J - no New Safety Signals Identified Through Two Years of Imaavy Treatment

THOMSON REUTERS
·
Sep 29

J&J - Presents New Data on Imaavy in Generalized Myasthenia Gravis

THOMSON REUTERS
·
Sep 29

J&J - Two-Year Phase 2/3 Data Shows Sustained Disease Control and Reduced Corticosteroid Use in Adolescents

THOMSON REUTERS
·
Sep 29